A phase Ib/II study of BBI608 combined with weekly paclitaxel in advanced pancreatic cancer.

被引：7
|
作者：
Bekaii-Saab, Tanios S.
Mikhail, Sameh
Langleben, Adrian
Becerra, Carlos
Jonker, Derek J.
Asmis, Timothy R.
Cote, Gregory Michael
Wu, Christina Sing-Ying
Kwak, Eunice Lee
Spira, Alexander I.
Braiteh, Fadi S.
Richey, Stephen Lane
Hume, Stephanie
Hitron, Matthew
Li, Chiang
机构：
[1] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Solove Res Inst, Columbus, OH 43210 USA
[2] St Marys Hosp, Westmount, PQ, Canada
[3] Texas Oncol, Baylor Sammons Canc Ctr, Dallas, TX USA
[4] Ottawa Hosp, Ctr Canc, Ottawa, ON, Canada
[5] Massachusetts Gen Hosp, Boston, MA 02114 USA
[6] Ohio State Univ, Ctr Comprehens Canc, Arthur G James Canc Hosp, Richard J Solove Res Inst, Columbus, OH 43210 USA
[7] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[8] Virginia Canc Specialists Res Inst, US Oncol Res, Fairfax, VA USA
[9] McKesson Specialty Hlth, US Oncol Network, The Woodlands, TX USA
[10] Texas Oncol, US Oncol Network, McKesson Specialty Hlth, Ft Worth, TX USA
[11] Boston Biomed Inc, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.196
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
196
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Scoop: Multicenter phase I/II trial of BBI608 and pembrolizumab in patients with metastatic colorectal cancer (EPOC1503)
    Hara, Hiroki
    Kawazoe, Akihito
    Kuboki, Yasutoshi
    Komatsu, Yoshito
    Nishina, Tomohiro
    Shinozaki, Eiji
    Yuki, Satoshi
    Takahashi, Koji
    Mikamoto, Yuichi
    Hirano, Nami
    Nomura, Shogo
    Togashi, Yosuke
    Nishikawa, Hiroyoshi
    Sato, Akihiro
    Ohtsu, Atsushi
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [22] Phase I/II study of carboplatin and weekly paclitaxel for advanced non-small cell lung cancer.
    Ohashi, N
    Arita, KI
    Daga, H
    Mito, A
    Nishino, R
    Moritani, C
    Nakamura, K
    Daido, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 687S - 687S
  • [23] Weekly cisplatin-epirubicin-paclitaxel in advanced breast cancer. A phase I study
    Frasci, G
    Comella, P
    Apicella, A
    D'Aiuto, G
    Thomas, R
    Capasso, I
    Di Bonito, M
    Piccolo, S
    Carteni, G
    Gravina, A
    Comella, G
    ANNALS OF ONCOLOGY, 1998, 9 : 98 - 98
  • [24] Phase II Study of Weekly Paclitaxel for Advanced or Metastatic Breast Cancer in Japan
    Horiguchi, Jun
    Rai, Yoshiaki
    Tamura, Kazuo
    Taki, Toshihiko
    Hisamatsu, Kazufumi
    Ito, Yoshinori
    Seriu, Taku
    Tajima, Tomoo
    ANTICANCER RESEARCH, 2009, 29 (02) : 625 - 630
  • [25] Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study
    De Lena, M
    Lorusso, V
    Latorre, A
    Fanizza, G
    Gargano, G
    Caporusso, L
    Guida, M
    Catino, A
    Crucitta, E
    Sambiasi, D
    Mazzei, A
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (03) : 364 - 368
  • [26] Phase II study of weekly albumin-bound paclitaxel combined with cisplatin in patients with advanced breast cancer
    Hu, X.
    Wang, B.
    BREAST, 2011, 20 : S77 - S77
  • [27] Phase II study of gemcitabine and Flutamide in advanced pancreatic cancer.
    Mayer, A
    Shaw, J
    D'Ath, S
    Price, P
    Blesing, C
    Corrie, P
    ANNALS OF ONCOLOGY, 2000, 11 : 68 - 68
  • [28] Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center
    Vo, Henry Hiep
    Cartwright, Carrie
    Song, I-Wen
    Karp, Daniel D.
    Nogueras Gonzalez, Graciela M.
    Xie, Yuran
    Karol, Michael
    Hitron, Matthew
    Vining, David
    Tsimberidou, Apostolia-Maria
    CANCERS, 2022, 14 (05)
  • [29] Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer.: A phase II study
    Frasci, G
    Comella, P
    D'Aiuto, G
    Budillon, A
    Barbarulo, D
    Thomas, R
    Capasso, I
    Casaretti, R
    Daponte, A
    Caponigro, F
    Gravina, A
    Maiorino, L
    Caratení, G
    Gentile, A
    Comella, G
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 49 (01) : 13 - 26
  • [30] A phase II study of weekly paclitaxel and doxifluridine (an intermediate metabolite of capecitabine) combination chemotherapy for advanced/recurrent gastric cancer.
    Takeyoshi, I
    Makita, F
    Tanahashi, Y
    Iwazaki, S
    Nakamura, S
    Ogawa, T
    Ishikawa, H
    Ohya, T
    Kawate, S
    Morishita, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 328S - 328S
12345